Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Conditions:   Locally Advanced Basal Cell Carcinoma;   Skin Cancer;   Cutaneous Malignancy
Interventions:   Drug: Vismodegib;   Radiation: Radiation therapy
Sponsors:   Sue Yom;   Genentech, Inc.
Recruiting - verified November 2016

http://ift.tt/2f8KTRm

Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer

Conditions:   Attenuated Familial Adenomatous Polyposis;   Familial Adenomatous Polyposis
Interventions:   Drug: Erlotinib Hydrochloride;   Other: Laboratory Biomarker Analysis
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting - verified November 2016

http://ift.tt/2f8LOkB

Durvalumab, an Anti-PD-L1 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer

Conditions:   Esophageal Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma
Interventions:   Biological: durvalumab;   Drug: carboplatin AUC 2/paclitaxel;   Radiation: External beam radiation;   Procedure: esophagogastrectomy
Sponsors:   Memorial Sloan Kettering Cancer Center;   AstraZeneca
Recruiting - verified November 2016

http://ift.tt/2extqWn

Exercise Prior to Oesophagectomy

Conditions:   Postoperative Complications (Cardiopulmonary);   Oesophageal Adenocarcinoma
Interventions:   Behavioral: Pre-operative Exercise Programme (my-PEP);   Behavioral: Home Exercise Programme (HEP)
Sponsor:   University of East Anglia
Recruiting - verified November 2016

http://ift.tt/2f8KbDB

Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

Condition:   Recurrent or Metastatic Head and Neck Carcinoma
Interventions:   Drug: vinflunine;   Drug: Methotrexate
Sponsor:   Pierre Fabre Medicament
Recruiting - verified November 2016

http://ift.tt/2exrc9m

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Conditions:   Locally Advanced Basal Cell Carcinoma;   Skin Cancer;   Cutaneous Malignancy
Interventions:   Drug: Vismodegib;   Radiation: Radiation therapy
Sponsors:   Sue Yom;   Genentech, Inc.
Recruiting - verified November 2016

http://ift.tt/2f8KTRm

Benign lymphoepithelial cyst of unusual location: A case report

Volume 1, Issue 1, December 2016, Page 110-112
.


http://ift.tt/2fqHHDo